Our Business

Phosphagenics Limited is a Melbourne-based biotechnology company which has developed a unique delivery technology based on tocopherol phosphate (Vitamin E phosphate).  This platform technology, known as TPM® is able to deliver actives and drugs into or through the skin.

Phosphagenics shares are listed on the Australian Securities Exchange (ASX: POH).  Phosphagenics ADR’s are also traded on the OTCQX in the USA.





 

Breaking News


3 March 2014

PHOSPHAGENICS APPOINTS THREE NEW NON-EXECUTIVE DIRECTORS

Phosphagenics has appointed biotech industry veterans Mr Lawrence Gozlan, Mr Nathan Drona and Dr Geert Cauwenbergh as non-executive directors, with Mr Gozlan assuming the role of Chairman of the Board on an interim basis. 

Mr Stuart James, Dr Sandra Webb, Mr Don Clarke and Mr Jonathan Addison have retired from the Board. The Company thanks them for their contributions over many years.

View our latest news releases/presentations/newsletters:

3 April 2014

PHOSPHAGENICS INVESTOR WEBCAST PRESENTATION

If you wish to listen to the webcast held, register here:
 http://public.viavid.com/player/index.php?id=108450

17 March 2014

PHOSPHAGENICS NEWSLETTER MARCH 2014


28 February 2014

PHOSPHAGENICS FINANCIAL REPORT 2013